rs727503376

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_000307.5(POU3F4):​c.483C>A​(p.Ser161Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000581 in 1,205,019 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.0000046 ( 0 hom. 3 hem. )

Consequence

POU3F4
NM_000307.5 missense

Scores

5
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.35
Variant links:
Genes affected
POU3F4 (HGNC:9217): (POU class 3 homeobox 4) This gene encodes a member of the POU-III class of neural transcription factors. This family member plays a role in inner ear development. The protein is thought to be involved in the mediation of epigenetic signals which induce striatal neuron-precursor differentiation. Mutations in this gene are associated with X chromosome-linked nonsyndromic mixed deafness. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.16076839).
BS2
High Hemizygotes in GnomAdExome4 at 3 Mitochondrial gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POU3F4NM_000307.5 linkuse as main transcriptc.483C>A p.Ser161Arg missense_variant 1/1 ENST00000644024.2 NP_000298.3 P49335A0A2R8Y739

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POU3F4ENST00000644024.2 linkuse as main transcriptc.483C>A p.Ser161Arg missense_variant 1/1 NM_000307.5 ENSP00000495996.1 A0A2R8Y739
ENSG00000279437ENST00000625081.1 linkuse as main transcriptn.408G>T non_coding_transcript_exon_variant 1/16

Frequencies

GnomAD3 genomes
AF:
0.0000178
AC:
2
AN:
112673
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34807
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000375
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000610
AC:
1
AN:
163989
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
52681
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000692
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000458
AC:
5
AN:
1092346
Hom.:
0
Cov.:
31
AF XY:
0.00000837
AC XY:
3
AN XY:
358634
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000250
Gnomad4 NFE exome
AF:
0.00000358
Gnomad4 OTH exome
AF:
0.0000218
GnomAD4 genome
AF:
0.0000178
AC:
2
AN:
112673
Hom.:
0
Cov.:
24
AF XY:
0.00
AC XY:
0
AN XY:
34807
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000375
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 24, 2014The Ser161Arg variant in POU3F4 has not been previously reported in individuals with hearing loss. Data from large population studies are insufficient to assess the frequency of this variant. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Ser161Arg variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Uncertain
0.027
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
16
DANN
Benign
0.91
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.74
.;T
M_CAP
Benign
0.059
D
MetaRNN
Benign
0.16
T;T
MetaSVM
Benign
-0.44
T
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.58
N;.
REVEL
Uncertain
0.32
Sift
Benign
0.10
T;.
Sift4G
Benign
0.51
T;.
Vest4
0.069
MutPred
0.22
Gain of catalytic residue at S161 (P = 0.0069);Gain of catalytic residue at S161 (P = 0.0069);
MVP
0.84
MPC
1.2
ClinPred
0.22
T
GERP RS
4.4
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs727503376; hg19: chrX-82763815; API